There were 13 recall notices issued for veterinary medicines that had been placed on the Irish market last year, to safeguard animal and public health, a new report has revealed.
The Health Products Regulatory Authority’s (HPRA) 2025 annual report states that almost half of those notices, six recalls, were issued on foot of particulate contamination concerns.
A further three were ordered due to manufacturers’ non-compliance with best practice.
Recalled brands' names or product types were not disclosed in the report.
A lack of assurance on sterility resulted in two recalls, while one product was ordered off shelves due to its stability landing out of specification. One further product was subjected to a recall due a product mix-up.
HPRA role
The HPRA is the authority responsible for licensing veterinary medicines in line with safety, quality and effectiveness standards, and it monitors the use of those products in animals once they hit the market.
It is also the authority responsible for giving the go-ahead to field trials, and it inspects and licenses manufacturing sites for veterinary medicines.
The body received almost 1,050 reports of adverse events in animals after a treatment with veterinary medicines, an increase of 18% from 883 in 2024.
The reports were submitted by vets, licensed retailers and animal owners, all of whom the HPRA has thanked for helping it assess the safety of veterinary medicines.
SHARING OPTIONS